Skip to main content

1-20 of 150 results for subject:Patients

Year X
2008
Subject X
Drugs

Type

House

Session

Month

Department

Member

More

Primary member

Answering member

Legislative stage

Legislation

Subject

More
Drugs (150)

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

Diabetes in the NHS: commissioning and providing specialist services. 26 p.

Deposited by
Department of Health
Type
Deposited papers
Date
9 December 2008
Reference
DEP2008-3016
House
House of Commons

asked Her Majesty's Government:Further to the Statement by the Parliamentary Under-Secretary of State for Justice, Maria Eagle, on 11 November (Official Report, House of Commons, col. 241WH) that the legal position on assisted dying is clear, whether a doctor may lawfully administer what she reasonably believes to be appropriate medical...

Asked by
Lord Lester of Herne Hill (Liberal Democrat)
Type
Written questions
Status
Answered
Date
26 November 2008
Reference
6494; 705 c292WA
House
House of Lords

Letter dated 04/11/2008 from David Nicholson, NHS Chief Executive, to strategic health authority chief executives regarding improving access to medicines for NHS patients. 4 p.

Deposited by
Department of Health
Type
Deposited papers
Date
24 November 2008
Reference
DEP2008-2828
House
House of Commons

Guidance on NHS patients who wish to pay for additional private care: a consultation. Consultation paper. 16 p.

Deposited by
Department of Health
Type
Consultation papers; Deposited papers
Date
24 November 2008
Reference
DEP2008-2825
House
House of Commons

asked Her Majesty's Government:Whether, if a patient makes a top-up payment for a cancer drug, the National Health Service will continue to pay for the treatment if the patient runs out of money.

Asked by
Lord Bradley (Labour)
Type
Written questions
Status
Answered
Date
17 November 2008
Reference
705 c167WA; 6161
House
House of Lords

Cost effective provision of disease modifying therapies for people with multiple sclerosis. Health Service Circular 2002/004. 29 p.

Deposited by
Department of Health
Type
Deposited papers
Date
12 November 2008
Reference
DEP2008-2700
House
House of Commons

Improving access to medicines for NHS patients. 77 p.

Deposited by
Department of Health
Type
Deposited papers
Date
12 November 2008
Reference
DEP2008-2698
House
House of Commons

Statement on the Richards Review of policy regarding NHS patients who wish to pay for additional private drugs. (Top-ups)

Lead member
Alan Johnson
Department
Department of Health
Type
Ministerial statements
Date
4 November 2008
Reference
482 c131-46
House
House of Commons

Lords statement on Professor Mike Richards' review of current policy concerning NHS patients who wish to pay for additional private drugs.

Lead member
Lord Darzi of Denham
Department
Department of Health
Type
Ministerial statements
Date
4 November 2008
Reference
705 c144-58
House
House of Lords

I am grateful to the Secretary of State for advance sight of his statement. I am sure, too, that the House will wish to thank Professor Mike Richards for his report. I regret, however, that the Secretary of State's statement, far from clarifying the issues, leaves them as unsatisfactory as...

Member
Lord Lansley (Conservative)
Type
Proceeding contributions
Date
4 November 2008
Reference
482 c133-6
House
House of Commons

My Lords, does the Minister think that the Statement will make postcode prescribing better or worse? Surely that is the real problem of a two-tier system.

Member
Baroness Masham of Ilton (Crossbench)
Type
Proceeding contributions
Date
4 November 2008
Reference
705 c156
House
House of Lords

I welcome the measures proposed in the statement, which will go a long way towards speeding up the process and making more drugs available. However, I have some concerns about what my right hon. Friend has said. One of the founding principles of the NHS is that it is based...

Member
Howard Stoate (Labour)
Type
Proceeding contributions
Date
4 November 2008
Reference
482 c140
House
House of Commons

I welcome the Secretary of State's statement and his recognition that some health economies, such as Birmingham's, have already successfully worked out a way of dealing with the private sector and the NHS. However, I did not quite get a sense of whether there is any distinction in the primary...

Member
Baroness Stuart of Edgbaston (Labour)
Type
Proceeding contributions
Date
4 November 2008
Reference
482 c141
House
House of Commons

My Lords, we are extremely grateful to the Minister for repeating an important Statement. It raises an important principle of care which I imagine will grow within the health service as our healthcare becomes increasingly complex and often quite expensive. One of the issues, however, is whether the principle might...

Member
Lord Winston (Labour)
Type
Proceeding contributions
Date
4 November 2008
Reference
705 c155
House
House of Lords

My Lords, I am grateful to the noble Lord. With regard to the interpretation of the guidance, it is obvious from the Richards report that there has been a large variation in the interpretation of the guidance in different parts of the country. That is why we are where we...

Member
Lord Darzi of Denham (Labour)
Type
Proceeding contributions
Date
4 November 2008
Reference
705 c153
House
House of Lords

That is a question for NICE in deciding how to operate the system. Currently, drugs companies come in with a price at the beginning and cannot alter it, but under a value-based system they could come in with a lower price and then argue for a higher price later. ...I...

Member
Alan Johnson (Labour)
Type
Proceeding contributions
Date
4 November 2008
Reference
482 c144-5
House
House of Commons

The decisions do not apply retrospectively. A NICE decision applies from the time at which it takes effect. In terms of the additional care that we are talking about, when NHS care is withdrawn from a patient in those circumstances that comes into effect immediately.

Member
Alan Johnson (Labour)
Type
Proceeding contributions
Date
4 November 2008
Reference
482 c146
House
House of Commons

I commend this positive step and remind the House of the heroic Jane Tomlinson, who did so much for charity but could not access the drugs that she needed. May I ask the Secretary of State a practical question about the ever-changing medicines available for people who are terminally ill?...

Member
Greg Mulholland (Liberal Democrat)
Type
Proceeding contributions
Date
4 November 2008
Reference
482 c145-6
House
House of Commons

Speedier NICE appraisal decisions are essential but they are not sufficient. We also need more transparency and accountability in NICE decisions. In the light of the Law Lords' decision to refuse permission to NICE to go to appeal on the dementia drug case decision, will the Secretary of State now...

Member
Paul Burstow (Liberal Democrat)
Type
Proceeding contributions
Date
4 November 2008
Reference
482 c146
House
House of Commons

I shall take that question as an audition for the Royal Shakespeare Company and treat it with the contempt it deserves.

Member
Alan Johnson (Labour)
Type
Proceeding contributions
Date
4 November 2008
Reference
482 c146
House
House of Commons